BR112017003710A2 - mono-, di- ou polissacarídeo usado como inibidor de metal na preparação de agente de direcionamento com grupamento funcional de 68ga-quelato - Google Patents
mono-, di- ou polissacarídeo usado como inibidor de metal na preparação de agente de direcionamento com grupamento funcional de 68ga-quelatoInfo
- Publication number
- BR112017003710A2 BR112017003710A2 BR112017003710A BR112017003710A BR112017003710A2 BR 112017003710 A2 BR112017003710 A2 BR 112017003710A2 BR 112017003710 A BR112017003710 A BR 112017003710A BR 112017003710 A BR112017003710 A BR 112017003710A BR 112017003710 A2 BR112017003710 A2 BR 112017003710A2
- Authority
- BR
- Brazil
- Prior art keywords
- mono
- preparation
- targeting agent
- metal inhibitor
- polysaccharide used
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
- A61K51/0482—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group chelates from cyclic ligands, e.g. DOTA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/008—Peptides; Proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
Abstract
a presente invenção refere-se à utilização de inibidor de metal em reações de radiomarcação usando metais radioativos.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR122021017474-1A BR122021017474B1 (pt) | 2014-08-29 | 2015-07-28 | Método para radiomarcação de um agente de direcionamento com grupamento funcional de quelato com um radionuclídeo de metal, e kit para radiomarcação |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BE2014/0653 | 2014-08-29 | ||
BE2014/0653A BE1021191B1 (fr) | 2014-08-29 | 2014-08-29 | Kit pour radiomarquage. |
PCT/EP2015/067213 WO2016030104A1 (en) | 2014-08-29 | 2015-07-28 | Mono-, di- or polysaccharide used as metal inhibitor in the preparation of 68ga-chelate-functionalized targeting agent |
Publications (2)
Publication Number | Publication Date |
---|---|
BR112017003710A2 true BR112017003710A2 (pt) | 2017-12-05 |
BR112017003710B1 BR112017003710B1 (pt) | 2021-12-14 |
Family
ID=52396314
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR122021017474-1A BR122021017474B1 (pt) | 2014-08-29 | 2015-07-28 | Método para radiomarcação de um agente de direcionamento com grupamento funcional de quelato com um radionuclídeo de metal, e kit para radiomarcação |
BR112017003710-6A BR112017003710B1 (pt) | 2014-08-29 | 2015-07-28 | Método para radiomarcação de um agente de direcionamento com grupamento funcional de quelato com um radionuclídeo de metal, e kit para radiomarcação |
BR112017003578-2A BR112017003578B1 (pt) | 2014-08-29 | 2015-07-28 | Kit para radiomarcação compreendendo gálio-68 e um inibidor de metal, seu uso e seus processos de preparação, e método e processo para radiomarcação de um agente alvo com gálio-68 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR122021017474-1A BR122021017474B1 (pt) | 2014-08-29 | 2015-07-28 | Método para radiomarcação de um agente de direcionamento com grupamento funcional de quelato com um radionuclídeo de metal, e kit para radiomarcação |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112017003578-2A BR112017003578B1 (pt) | 2014-08-29 | 2015-07-28 | Kit para radiomarcação compreendendo gálio-68 e um inibidor de metal, seu uso e seus processos de preparação, e método e processo para radiomarcação de um agente alvo com gálio-68 |
Country Status (19)
Country | Link |
---|---|
US (6) | US11045563B2 (pt) |
EP (4) | EP3185911B1 (pt) |
JP (2) | JP6543343B2 (pt) |
CN (2) | CN106794265B (pt) |
AU (7) | AU2015309187B2 (pt) |
BE (1) | BE1021191B1 (pt) |
BR (3) | BR122021017474B1 (pt) |
CA (3) | CA2958475C (pt) |
DK (1) | DK3185911T3 (pt) |
ES (2) | ES2855991T3 (pt) |
HU (1) | HUE053971T2 (pt) |
IL (2) | IL250735B (pt) |
MX (2) | MX2017002362A (pt) |
NZ (1) | NZ729293A (pt) |
PL (1) | PL3185911T3 (pt) |
PT (1) | PT3185911T (pt) |
RU (2) | RU2725627C2 (pt) |
WO (2) | WO2016030103A1 (pt) |
ZA (1) | ZA201702152B (pt) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11027030B2 (en) | 2014-08-29 | 2021-06-08 | Anmi S.A. | Kit for radiolabelling |
BE1021191B1 (fr) * | 2014-08-29 | 2015-10-27 | Anmi S.A. | Kit pour radiomarquage. |
GB201504064D0 (en) * | 2015-03-10 | 2015-04-22 | Accretion Biotechnology Ltd | Method and kits for preparing radionuclide complexes |
CN106377527B (zh) * | 2016-09-05 | 2019-02-26 | 郑州大学 | 开链吡啶羧酸衍生物H2dedpa在抗菌领域的应用 |
JP2020518673A (ja) | 2017-05-05 | 2020-06-25 | フュージョン・ファーマシューティカルズ・インコーポレイテッド | 二官能性キレートの薬物動態増強及びその使用 |
IL313115A (en) | 2017-05-05 | 2024-07-01 | Centre For Probe Dev And Commercialization | R1–IGF monoclonal antibodies and their use |
US10093741B1 (en) | 2017-05-05 | 2018-10-09 | Fusion Pharmaceuticals Inc. | IGF-1R monoclonal antibodies and uses thereof |
EP3720510A1 (en) * | 2017-12-08 | 2020-10-14 | Ecs-biotracker Sàrl | Radiolabeled progastrin in cancer diagnosis |
WO2019246445A1 (en) * | 2018-06-20 | 2019-12-26 | The Research Foundation For The State University Of New York | Triazamacrocycle-derived chelator compositions for coordination of imaging and therapy metal ions and methods of using same |
CN110787186B (zh) * | 2019-10-22 | 2020-11-17 | 华中科技大学 | 一种Ga3+/PDA靶向协同抗菌纳米材料、其制备和应用 |
IT202000032603A1 (it) | 2020-12-29 | 2022-06-29 | Univ Degli Studi Di Bari Aldo Moro | Kit freddi a base di ligandi del psma per l’allestimento di radiofarmaci. |
WO2022253785A2 (en) | 2021-05-31 | 2022-12-08 | Universität Heidelberg | Improved prostate-specific membrane antigen targeting radiopharmaceuticals and uses thereof |
KR20240051918A (ko) | 2021-06-29 | 2024-04-22 | 라이프 몰레큘러 이미징 리미티드 | 방사성금속 표지된 킬레이트-관능화된 표적화 접합체의 방사성약제 제조를 위한 신규 키트 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL7902342A (nl) | 1979-03-26 | 1980-09-30 | Byk Mallinckrodt Cil Bv | Isotopengenerator. |
US7230085B2 (en) | 2001-11-28 | 2007-06-12 | Immunomedics, Inc. | Anti-DOTA antibody |
US7011816B2 (en) * | 2001-12-26 | 2006-03-14 | Immunomedics, Inc. | Labeling targeting agents with gallium-68 and gallium-67 |
ES2398393T3 (es) * | 2002-03-01 | 2013-03-15 | Dyax Corp. | Péptidos de unión a KDR y a VEGF/KDR y su uso en diagnóstico y terapia |
US7597876B2 (en) * | 2007-01-11 | 2009-10-06 | Immunomedics, Inc. | Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules |
GB0308408D0 (en) | 2003-04-11 | 2003-05-21 | Amersham Plc | Microwave activation |
KR101106533B1 (ko) * | 2003-07-24 | 2012-01-20 | 브라코 이미징 에스.피.에이. | 안정한 방사성의약 조성물 및 제조 방법 |
US8147805B2 (en) | 2005-01-05 | 2012-04-03 | The Board of Regents of The University of T exas System | Conjugates for dual imaging and radiochemotherapy: composition, manufacturing, and applications |
US8545809B2 (en) | 2007-01-11 | 2013-10-01 | Immunomedics, Inc. | Methods and compositions for improved 18F labeling of proteins, peptides and other molecules |
BRPI0809442A2 (pt) | 2007-03-27 | 2014-09-09 | Radiomedix Inc | Composições para terapia e formação de imagens direcionada |
FR2942227B1 (fr) * | 2009-02-13 | 2011-04-15 | Guerbet Sa | Utilisation de tampons pour la complexation de radionucleides |
US20120164111A1 (en) * | 2009-04-14 | 2012-06-28 | Kurt Osther | Novel post-translational fibrinogen variants |
WO2010141833A2 (en) | 2009-06-05 | 2010-12-09 | The General Hospital Corporation | Vital fluorochrome conjugates and methods of use |
US8951064B2 (en) | 2010-12-14 | 2015-02-10 | Ideal Industries, Inc. | Terminal structures for wiring devices |
ITFI20110180A1 (it) | 2011-08-12 | 2013-02-13 | Advanced Accelerator Applic S A | Processo per la preparazione di complessi di 68ga. |
US9161998B2 (en) * | 2012-05-18 | 2015-10-20 | Zentralklinik Bad Berka Gmbh | Method and kit for preparing a radiopharmaceutical |
US20150246146A1 (en) * | 2012-10-25 | 2015-09-03 | Life Technologies Corporation | Methods and compositions for enzyme-mediated site-specific radiolabeling of glycoproteins |
US11027030B2 (en) | 2014-08-29 | 2021-06-08 | Anmi S.A. | Kit for radiolabelling |
BE1021191B1 (fr) | 2014-08-29 | 2015-10-27 | Anmi S.A. | Kit pour radiomarquage. |
CN104830316B (zh) * | 2015-05-11 | 2017-02-01 | 厦门大学 | 一种用于核素标记的靶向探针及其制备方法和应用 |
ITUA20163207A1 (it) | 2016-05-06 | 2017-11-06 | Azienda Ospedaliera Di Reggio Emilia Arcispedale Santa Maria Nuova | Preparazione in kit di radiofarmaci marcati con gallio-68 |
-
2014
- 2014-08-29 BE BE2014/0653A patent/BE1021191B1/fr active
-
2015
- 2015-07-28 CA CA2958475A patent/CA2958475C/en active Active
- 2015-07-28 EP EP15748207.6A patent/EP3185911B1/en active Active
- 2015-07-28 RU RU2017109582A patent/RU2725627C2/ru active
- 2015-07-28 ES ES15748207T patent/ES2855991T3/es active Active
- 2015-07-28 PT PT157482076T patent/PT3185911T/pt unknown
- 2015-07-28 CN CN201580046266.2A patent/CN106794265B/zh active Active
- 2015-07-28 US US15/505,945 patent/US11045563B2/en active Active
- 2015-07-28 AU AU2015309187A patent/AU2015309187B2/en active Active
- 2015-07-28 BR BR122021017474-1A patent/BR122021017474B1/pt active IP Right Grant
- 2015-07-28 NZ NZ729293A patent/NZ729293A/en unknown
- 2015-07-28 PL PL15748207T patent/PL3185911T3/pl unknown
- 2015-07-28 BR BR112017003710-6A patent/BR112017003710B1/pt active IP Right Grant
- 2015-07-28 EP EP15748208.4A patent/EP3185912B1/en active Active
- 2015-07-28 ES ES15748208T patent/ES2856030T3/es active Active
- 2015-07-28 BR BR112017003578-2A patent/BR112017003578B1/pt active IP Right Grant
- 2015-07-28 CN CN201580046784.4A patent/CN106659806B/zh active Active
- 2015-07-28 JP JP2017530410A patent/JP6543343B2/ja active Active
- 2015-07-28 AU AU2015309188A patent/AU2015309188B2/en active Active
- 2015-07-28 JP JP2017530411A patent/JP6552622B2/ja active Active
- 2015-07-28 EP EP20217374.6A patent/EP3862026A1/en active Pending
- 2015-07-28 US US15/505,941 patent/US11040120B2/en active Active
- 2015-07-28 EP EP20217371.2A patent/EP3862025A1/en active Pending
- 2015-07-28 CA CA2958471A patent/CA2958471C/en active Active
- 2015-07-28 MX MX2017002362A patent/MX2017002362A/es unknown
- 2015-07-28 RU RU2017109583A patent/RU2724894C2/ru active
- 2015-07-28 MX MX2017002361A patent/MX2017002361A/es unknown
- 2015-07-28 HU HUE15748207A patent/HUE053971T2/hu unknown
- 2015-07-28 CA CA3167294A patent/CA3167294C/en active Active
- 2015-07-28 WO PCT/EP2015/067211 patent/WO2016030103A1/en active Application Filing
- 2015-07-28 WO PCT/EP2015/067213 patent/WO2016030104A1/en active Application Filing
- 2015-07-28 DK DK15748207.6T patent/DK3185911T3/da active
-
2017
- 2017-02-23 IL IL250735A patent/IL250735B/en active IP Right Grant
- 2017-02-23 IL IL250736A patent/IL250736B/en active IP Right Grant
- 2017-03-27 ZA ZA2017/02152A patent/ZA201702152B/en unknown
-
2020
- 2020-08-21 AU AU2020220193A patent/AU2020220193A1/en not_active Abandoned
- 2020-08-21 AU AU2020220194A patent/AU2020220194A1/en not_active Abandoned
-
2021
- 2021-05-19 US US17/324,243 patent/US20210268131A1/en active Pending
- 2021-05-20 US US17/325,258 patent/US20210275697A1/en active Pending
-
2022
- 2022-04-07 AU AU2022202346A patent/AU2022202346A1/en not_active Abandoned
- 2022-04-13 AU AU2022202439A patent/AU2022202439B2/en active Active
- 2022-05-12 US US17/742,502 patent/US20220273827A1/en active Pending
- 2022-05-31 US US17/828,199 patent/US20220296735A1/en active Pending
-
2024
- 2024-07-26 AU AU2024205118A patent/AU2024205118A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112017003710A2 (pt) | mono-, di- ou polissacarídeo usado como inibidor de metal na preparação de agente de direcionamento com grupamento funcional de 68ga-quelato | |
GT201800090A (es) | Anticuerpos que se unen específicamente a pd-1 y sus usos | |
BR112017009497A2 (pt) | polinucleotídeos de aadc para o tratamento da doença de parkinson | |
BR112017023853A2 (pt) | composições de nanopartícula para terapia sustentada. | |
CL2014002258A1 (es) | Anticuerpos dirigidos contra metaloproteinasas de matriz 9 (mmp9 gelatinasa b); composicion farmaceutica que lo contiene; y sus usos. | |
BR112016017112A2 (pt) | Composições de apilimod e métodos de uso das mesmas | |
BR112018003178A2 (pt) | absorvente feminino com braçadeiras de barreira | |
EP3649577C0 (en) | APPLICATION FOR DETERMINING A READING/WORKING DISTANCE | |
FR3013218B1 (fr) | Composition comprenant des capsules gelifiees stabilisees par un tampon | |
AR102677A1 (es) | Composición que comprende sal de acil glutamato como agente tensoactivo primario o agente tensoactivo aniónico primario y polímeros estructurantes específicos | |
BR112017018834A2 (pt) | variantes de protoxina-ii e métodos de uso | |
BR112017011168A2 (pt) | medicamentos para retardar a doença de parkinson | |
BR112017008481A2 (pt) | composto antimicótico | |
BR122020011331B8 (pt) | Artigo absorvente | |
ZA201704869B (en) | Working neutron source | |
BR112016007062A2 (pt) | variantes de protoxina-ii e métodos de uso | |
BR112017020896A2 (pt) | variantes de protoxina-ii e métodos de uso | |
DK3296485T3 (da) | Ståldrager | |
DOP2017000058A (es) | Derivados de tetrahidroquinolina como inhibidores del bromodominio | |
EP2980195A4 (en) | HYDROSOLUBLE OILY AGENT FOR THE WORKING OF METALS | |
BR112018006446A2 (pt) | composições lubrificantes e métodos para uso das mesmas | |
CL2016002677A1 (es) | Compuestos heteroaromáticos y su uso como ligandos de dopamina d1. | |
BR112017011994A2 (pt) | composições de sal metálico | |
BR112016026774A2 (pt) | uso de inibidores de proteassoma contendo boro após terapia de câncer primária e composição farmacêutica. | |
PH12017500923A1 (en) | New dosage and use of a a2a antagonist |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 28/07/2015, OBSERVADAS AS CONDICOES LEGAIS. |
|
B25D | Requested change of name of applicant approved |
Owner name: TELIX INNOVATIONS S.A. (BE) |
|
B25G | Requested change of headquarter approved |
Owner name: TELIX INNOVATIONS S.A. (BE) |